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Abstract (No more than 400 words): 
 
Paracetamol is used clinically for the treatment of pain and fever. Recent investigations in 
experimental animals confirmed paracetamol is able to induce potent hypothermia, which 
is self-reversible and does not lead to any long term toxicities. In this investigation, the 
authors sought to investigate the mechanism through which paracetamol induces 
hypothermia in experimental animals. The authors present strong scientific evidence, 
which demonstrate that the paracetamol-induced hypothermia is mediated through 
inhibition of the activity of the novel cyclooxygenase (COX) enzyme, COX-3. Further 
investigations confirm that the paracetamol induced hypothermia is not dependent on 
interactions with the endocannabinoid or transient receptor potential vanillid-1 (TRPV-1). In 
addition, co-administration of paracetamol with a cannabinoid agonist resulted in 
synergistic hypothermia. These data provide a strong rationale for the use of paracetamol 
along with a cannabinoid agonist for the induction of therapeutic hypothermia in the clinic. 
Hypothermia is induced for therapeutic purposes in critically ill patients presenting to the 
clinic with stroke, cardiac arrest or neurotrauma. However, the current approaches used for 
the induction of therapeutic hypothermia are inefficient, slow and can only be performed in 
the hospital setting. Most of the neuronal damage takes place during the first hour 
following the development of critical illness. Having provided evidence on the mechanism 
of paracetamol-induced hypothermia and the fact that paracetamol and cannabinoid 
agonists induced synergistic hypothermia, we propose that combination therapy can be 
translated to the clinic for the induction of therapeutic hypothermia. The advantages that 
drug-induced therapeutic hypothermia offer over the currently used methods for the 
induction of therapeutic hypothermia include fact onset of hypothermia; within a few 
minutes as opposed to 30-60 minutes. This approach offers a cheap and readily available 
method for the induction of therapeutic hypothermia that has the potential of saving 
thousands of lives.       
 
  
 
